Menu
Back to User profile » Dr David B Rubin
Papers published by Dr David B Rubin:
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
Pavord ID, Chapman KR, Bafadhel M, Sciurba FC, Bradford ES, Schweiker Harris S, Mayer B, Rubin DB, Yancey SW, Paggiaro P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1755-1770
Published Date: 16 June 2021
Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness
Horne BD, Ali R, Midwinter D, Scott-Wilson C, Crim C, Miller BE, Rubin DB
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:41-51
Published Date: 7 January 2021
Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trials
Rubin DB, Ahmad HA, O'Neal M, Bennett S, Lettis S, Galkin DV, Crim C
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:189-201
Published Date: 8 January 2018
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD
Bhatt SP, Dransfield MT, Cockcroft JR, Wang-Jairaj J, Midwinter DA, Rubin DB, Scott-Wilson CA, Crim C
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:351-365
Published Date: 19 January 2017
Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
DiSantostefano RL, Li H, Hinds D, Galkin DV, Rubin DB
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:457-468
Published Date: 7 May 2014